Sobi

Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Sobi agrees to buy CTI BioPharma for $1.7bn
Pharmaceutical Technology
Thu, 05/11/23 - 09:50 am
Sobi
CTI BioPharma
M&A
hematology
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Biopharma Reporter
Wed, 04/12/23 - 11:30 am
Sanofi
AstraZeneca
Sobi
Beyfortus
RSV
Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon
Fierce Biotech
Tue, 03/21/23 - 10:00 am
Sobi
Selecta Biosciences
gout
SEL-212
Horizon Therapeutics
Krystexxa
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
FDA signs off on Sobi's Kineret for COVID patients with pneumonia who are on oxygen
Fierce Pharma
Wed, 11/9/22 - 11:17 pm
FDA
Sobi
Kineret
COVID-19
ADC Therapeutics cuts deal with Sobi to broaden reach of cancer drug
BioPharma Dive
Sun, 07/10/22 - 11:40 pm
ADC Therapeutics
Sobi
Zylonta
cancer
Europe
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Fierce Biotech
Wed, 03/9/22 - 10:54 am
Sanofi
Roche
Sobi
hemophilia A
clinical trials
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
AstraZeneca
Alexion
Sobi
M&A
Sobi agrees $8bn takeover offer from Advent and GIC
Pharmaceutical Business Review
Fri, 09/3/21 - 10:59 am
Sobi
M&A
Advent International
GIC
Nearly 70% of Akcea's workforce is on the chopping block as Ionis executes major restructuring
Endpoints
Tue, 04/6/21 - 11:04 pm
Akcea
Ionis
layoffs
Sobi
AstraZeneca pays Sobi $95M for priority review voucher
Fierce Biotech
Thu, 08/22/19 - 11:57 am
AstraZeneca
FDA
Sobi
priority review vouchers
roxadustat
Sobi to buy Novimmune R&D assets, lay off 90 staff
Fierce Biotech
Wed, 06/12/19 - 10:05 am
Sobi
Novimmune
R&D
layoffs
Sobi’s $50M bet on a rare disease drug pays off with a quick FDA nod
Endpoints
Tue, 11/20/18 - 08:33 pm
Sobi
FDA
emapalumab
Gamifant
HLH
AstraZeneca makes $1B-plus in cash-and-stock deal granting Sobi US rights to RSV drug Synagis
Endpoints
Tue, 11/13/18 - 10:29 am
AstraZeneca
Sobi
Synagis
RSV
Sobi signs $450M deal for rare disease drug emapalumab, boosting its inflammation, I/O pipeline
Endpoints
Sat, 07/21/18 - 12:02 am
Sobi
Novaimmune
inflammation
Swedish Orphan Plunges After Talks End on Potential Takeover
Bloomberg
Mon, 06/8/15 - 11:24 am
M&A
Swedish Orphan Biovitrum
Sobi
Pfizer emerges as mystery bidder for rare disease firm Swedish Orphan
BioPharma Dive
Fri, 05/1/15 - 10:17 am
Pfizer
M&A
Swedish Orphan Biovitrum
Sobi
Biogen partner Sobi and its Boston-based CEO field a takeover bid
Fierce Biotech
Mon, 04/27/15 - 09:41 am
Sobi
Swedish Orphan Biovitrum
Biogen
M&A